Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery tec...
Q1 2026
May 11, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 8, 2025